OHB's Five-Day Slide: When a Sound Order Book Meets a Sector-Wide Storm
Published on 08/25/2026 at 05:22 | Redaktion boerse-global.de
The arithmetic of the past week makes for uncomfortable reading in Bremen. OHB's share price has now fallen for five consecutive sessions, with Monday's drop of around 9.5 percent taking the stock to roughly €202 and leaving it rooted to the bottom of the SDAX. Yet the trigger has nothing to do with the company's own operations — no missed guidance, no contract cancellation, no management wobble. Instead, the German space and defence group finds itself collateral damage in a sector-wide retreat that has been gathering force since SpaceX's market debut in mid-June.
That IPO has cast a long shadow. SpaceX shares, which once soared to $225.64, have since tumbled well below their $135 issue price, and the fallout is being felt across the entire space complex. OHB, which had ridden the sector's enthusiasm to an all-time high of €685 back in May, is now paying the price for that earlier exuberance. The correction has accelerated sharply in recent days, and the stock sits roughly 26 percent beneath its 50-day moving average of €273.87.
What makes the slide particularly galling for long-term holders is the timing. The sell-off has steamrollered a succession of genuinely positive developments. A €1 billion order for 18 satellites under Europe's Iris² programme, announced in mid-August, has been followed by a 13.7 percent decline. Even the company's promotion to the SDAX — a move that replaced Klöckner & Co and might ordinarily have served as a quality badge — has coincided with a 22.2 percent cumulative loss. Deutsche Bank's initiation of coverage with a buy rating three weeks ago has fared little better, with the shares down 14.3 percent since.
The disconnect between price action and fundamentals is stark. When OHB published its first-half results just over three weeks ago, the numbers pointed firmly upward. Group revenue climbed 11 percent to €627.9 million from €563.5 million a year earlier. Adjusted EBITDA jumped 31 percent to €60.4 million, while adjusted EBIT surged 46 percent to €38.9 million. The order book expanded to €3.304 billion from €3.067 billion — more than five times the half-year revenue figure — and management reaffirmed its full-year guidance for an EBITDA margin of 10.5 to 11.0 percent on total output of around €1.4 billion. The medium-term targets remain equally ambitious: total output above €4 billion and an EBITDA margin near 13 percent.
The balance sheet, too, has rarely looked healthier. The capital increase completed in June brought in gross proceeds of €480 million and pushed the net leverage ratio to a comfortable -1.1x. The Fuchs family still controls more than 60 percent of the shares, with KKR holding roughly 20 percent, leaving only about a fifth of the equity in free float. That thin float cuts both ways: it amplifies moves in either direction and leaves the stock vulnerable to outsized swings on modest trading volumes. With annualised volatility running at 64 percent, nervousness is plainly baked into the current price.
There have been further contract wins to bolster the narrative. In late July, the Italian subsidiary OHB Italia secured an order from the space agency ASI for the PRISMA Second Generation Earth-observation mission, with launch targeted by the end of 2031. The technical picture, meanwhile, hints at exhaustion among sellers: the Relative Strength Index stands at roughly 31.4, a level that often precedes a bounce, though technicians would caution that an oversold reading alone is not a reversal signal.
While markets swing on sentiment, one area where discipline always pays off is workplace safety. A free Risk Assessment Toolkit with 41 ready-to-use templates helps you document hazards systematically and stay compliant — no matter how volatile the business climate gets. Download the free Risk Assessment Toolkit
The central question for investors is whether this is merely a sentiment-driven sector correction or the beginning of a more fundamental reassessment. The evidence so far points firmly to the former. Nothing in the operational data has deteriorated since the half-year numbers were published; the order book remains intact and no profit warning has been issued. The risk is contagion: as long as SpaceX functions as the mood anchor for the entire industry, OHB has limited ability to chart its own course, however sound its own metrics.
The next meaningful catalyst is the third-quarter report due on 12 November, which will show whether operational strength can finally steady the share price. In the nearer term, however, the direction of the stock may depend less on OHB itself than on whether the wider space sector's nerves can settle. The Iris² satellites are not scheduled to launch until 2029 — a timeline too distant to offer any immediate trading impetus. For now, the market is pricing sentiment, not substance, and the gap between the two is where the opportunity — or the trap — lies.
